The agreement is for Kashiv BioSciences’ biosimilar candidate to Genentech and Novartis AG’s Xolair (omalizumab) in the ...

A new study published in the Journal of American Medical Association found that Rilzabrutinib decreased itching and hives ...

A new international study led by researchers at McMaster University has identified the most effective and safest treatments ...

Scientists at Northwestern University have discovered a drug that could offer a new approach to treating life-threatening ...

Among adults with severe asthma, those with healthy weight, overweight, obesity and severe obesity each had improvements in ...

Discover the latest advancements in biosimilars, including tocilizumab's new indication, and partnerships for omalizumab and ...

Northwestern study finds asthma drug Zileuton offers promising food allergy treatment by nearly eliminating food-induced ...

The new-generation drug – also known as QGE031 – binds more tightly to IgE than Roche-partnered Xolair (omalizumab), and that suggests it could be more effective as a treatment for CSU, a ...

Novartis closes on filings for oral BTK drug remibrutinib as a treatment for chronic spontaneous urticaria after reporting 52-week data.

Researchers analyze the quality of monoclonal antibody biosimilars in Japan, revealing variations that impact adoption and ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.